New Press Release Kogenate FS is now approved for routine prophylactic treatment to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A. Learn More

If it matters to you,it matters to us

scroll to
learn more

Kogenate® FS antihemophilic factor (recombinant) is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Kogenate FS is used to prevent or control bleeding in adults and children with hemophilia A. Your healthcare provider may give you Kogenate FS when you have surgery. Kogenate FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis). Kogenate FS can reduce the risk of joint damage in children without preexisting joint damage when used regularly. Kogenate FS is not used to treat von Willebrand disease.

It's not a short-term relationship. It's a long-
term commitment.

“As your Bayer Hemophilia A representative, my role is to be involved – with you, your pharmacists, nurses, community advocates and local hemophilia A chapters.”

Steve Henson
Bayer HealthCare Rep Since 1997

Kogenate® FS – because your treatment matters

Learn about Kogenate FS

You should not use Kogenate FS if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Kogenate FS.

Tell your healthcare provider if you have been told you have heart disease or are at risk for heart disease.

You could have an allergic reaction to Kogenate FS. Call your healthcare provider right away and stop treatment if you get rash or hives, itching, tightness of the chest or throat, difficulty breathing, light-headed, dizziness, nausea or a decrease in blood pressure.

Your body can make antibodies, called "inhibitors," against Kogenate FS, which may stop Kogenate FS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to factor VIII.

The Kogenate® FS Free Trial Program is available to newly diagnosed patients and patients who are currently using other FVIII therapy. Patients currently using Kogenate® FS are not eligible for the Free Trial Program. Participation in the Kogenate® FS Free Trial Program is limited to one time each for both BIO-SET® and Vial Adapter reconstitution devices. The medication provided through this program is complimentary and is not an obligation to purchase or use Kogenate® FS in the future. Reselling or billing any third party for the free product is prohibited by law.

Because insurance and cost are always important matters

Need help understanding your insurance benefits or getting coverage between jobs? Factor Solutions specialists are here to help with these challenges and more. Conveniently. Easily. Personally.

Get insurance support

1-800-288-8374

People with private, commercial health insurance may receive Kogenate FS co-pay or co-insurance assistance on a first-come, first-served basis — based on eligibility requirements and income level. Financial support is available for up to 12 months or until the program ends. The program is not for patients receiving prescription reimbursement under any federal-, state-, or government-funded insurance programs, or where prohibited by law. All people who meet these criteria are encouraged to apply.

Get support.
Be connected.

Factor Matters is a support program designed to connect you to people, resources, and personalized information related to living with hemophilia A.

Sign up now